Aeolus Pharmaceuticals Inc (AOLS) - Financial and Strategic SWOT Analysis Review

Date: February 15, 2017
Pages: 42
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AB8A2D7FE17EN
Leaflet:

Download PDF Leaflet

Aeolus Pharmaceuticals Inc (AOLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant particularly designed to neutralize reactive oxygen and nitrogen species. AEOL-10150 compound is funded by the U.S. Government aimed at developing as a medical countermeasure against national security threats. The compound is being developed as a medical countermeasure against the delayed effects of acute radiation exposure and the pulmonary effects of acute radiation syndrome under an agreement with the Biomedical Advanced Research and Development Authority (BARDA), a division of the United States Department of Health and Human Services (HHS). Aeolus is headquartered in Mission Viejo, California, the US.

Aeolus Pharmaceuticals Inc Key Recent Developments

Dec 21, 2016: Aeolus Announces Fiscal Year 2016 Financial Results
Aug 15, 2016: Aeolus Announces Third Quarter Fiscal Year 2016 Financial Results
May 16, 2016: Aeolus Announces Second Quarter Fiscal Year 2016 Financial Results and Investor Update Call
Feb 16, 2016: Aeolus Announces First Quarter Fiscal Year 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Aeolus Pharmaceuticals Inc - Key Facts
Aeolus Pharmaceuticals Inc - Key Employees
Aeolus Pharmaceuticals Inc - Key Employee Biographies
Aeolus Pharmaceuticals Inc - Major Products and Services
Aeolus Pharmaceuticals Inc - Pharmaceutical Pipeline Products Data
Aeolus Pharmaceuticals Inc, Pipeline Products by Therapy Area
Aeolus Pharmaceuticals Inc, Pipeline Products by Development Phase
Aeolus Pharmaceuticals Inc - History
Aeolus Pharmaceuticals Inc - Company Statement
Aeolus Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Aeolus Pharmaceuticals Inc - Business Description
Aeolus Pharmaceuticals Inc - Corporate Strategy
Aeolus Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Aeolus Pharmaceuticals Inc - Strengths
Aeolus Pharmaceuticals Inc - Weaknesses
Aeolus Pharmaceuticals Inc - Opportunities
Aeolus Pharmaceuticals Inc - Threats
Aeolus Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Dec 21, 2016: Aeolus Announces Fiscal Year 2016 Financial Results
Aug 15, 2016: Aeolus Announces Third Quarter Fiscal Year 2016 Financial Results
May 16, 2016: Aeolus Announces Second Quarter Fiscal Year 2016 Financial Results and Investor Update Call
Feb 16, 2016: Aeolus Announces First Quarter Fiscal Year 2016 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Aeolus Pharmaceuticals Inc, Key Facts
Aeolus Pharmaceuticals Inc, Key Employees
Aeolus Pharmaceuticals Inc, Key Employee Biographies
Aeolus Pharmaceuticals Inc, Major Products and Services
Aeolus Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area
Aeolus Pharmaceuticals Inc, Number of Pipeline Products by Development Stage
Aeolus Pharmaceuticals Inc, History
Aeolus Pharmaceuticals Inc, Subsidiaries
Aeolus Pharmaceuticals Inc, Key Competitors
Aeolus Pharmaceuticals Inc, Ratios based on current share price
Aeolus Pharmaceuticals Inc, Annual Ratios
Aeolus Pharmaceuticals Inc (Cont...1), Annual Ratios
Aeolus Pharmaceuticals Inc, Interim Ratios
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios 41

LIST OF FIGURES

Aeolus Pharmaceuticals Inc, Pipeline Products by Therapy Area
Aeolus Pharmaceuticals Inc, Pipeline Products by Development Phase
Aeolus Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Aeolus Pharmaceuticals Inc, Ratio Charts
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

LIST OF TABLES

Aeolus Pharmaceuticals Inc, Key Facts
Aeolus Pharmaceuticals Inc, Key Employees
Aeolus Pharmaceuticals Inc, Key Employee Biographies
Aeolus Pharmaceuticals Inc, Major Products and Services
Aeolus Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area
Aeolus Pharmaceuticals Inc, Number of Pipeline Products by Development Stage
Aeolus Pharmaceuticals Inc, History
Aeolus Pharmaceuticals Inc, Subsidiaries
Aeolus Pharmaceuticals Inc, Key Competitors
Aeolus Pharmaceuticals Inc, Ratios based on current share price
Aeolus Pharmaceuticals Inc, Annual Ratios
Aeolus Pharmaceuticals Inc (Cont...1), Annual Ratios
Aeolus Pharmaceuticals Inc, Interim Ratios
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios 41

LIST OF FIGURES

Aeolus Pharmaceuticals Inc, Pipeline Products by Therapy Area
Aeolus Pharmaceuticals Inc, Pipeline Products by Development Phase
Aeolus Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Aeolus Pharmaceuticals Inc, Ratio Charts
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Aeolus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Skip to top


Ask Your Question

Aeolus Pharmaceuticals Inc (AOLS) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: